1. Melmed, S, Casanueva, FF, Hoffman, AR, et al. Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96:273-288.
Google Scholar | Crossref | Medline | ISI2. Levine, S, Muneyyirci-Delale, O. Stress-induced hyperprolactinemia: pathophysiology and clinical approach. Obstet Gynecol Int. 2018;2018:9253083.
Google Scholar | Crossref | Medline3. Vilar, L, Vilar, CF, Lyra, R, Da Conceição Freitas, M. Pitfalls in the diagnostic evaluation of hyperprolactinemia. Neuroendocrinology. 2019;109:7–19.
Google Scholar | Crossref | Medline4. Casanueva, FF, Molitch, ME, Schlechte, JA, et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol. 2006;65:265-273.
Google Scholar | Crossref | Medline | ISI5. Thapa, S, Bhusal, K. Hyperprolactinemia. StatPearls Publishing; 2020. https://www.ncbi.nlm.nih.gov/books/NBK537331/
Google Scholar6. Saleem, M, Martin, H, Coates, P. Prolactin biology and laboratory measurement: an update on physiology and current analytical issues. Clin Biochem Rev. 2018;39:3–16.
Google Scholar | Medline7. Samson, SL, Hamrahian, AH, Ezzat, S. American association of clinical endocrinologists, American college of endocrinology disease state clinical review: clinical relevance of macroprolactin in the absence or presence of true hyperprolactinemia. Endocr Pract. 2015;21:1427-1435.
Google Scholar | Crossref | Medline8. Whyte, MB, Pramodh, S, Srikugan, L, et al. Importance of cannulated prolactin test in the definition of hyperprolactinaemia. Pituitary. 2015;18:319-325.
Google Scholar | Crossref | Medline9. Capozzi, A, Scambia, G, Pontecorvi, A, Lello, S. Hyperprolactinemia: pathophysiology and therapeutic approach. Gynecol Endocrinol. 2015;31:506-510.
Google Scholar | Crossref | Medline | ISI10. Che Soh, N, Yaacob, N, Omar, J, et al. Global prevalence of macroprolactinemia among patients with hyperprolactinemia: a systematic review and meta-analysis. Int J Environ Res Public Health. 2020;17:8199.
Google Scholar | Crossref11. Ferriani, RA, Silva, de, Sá, MF. Effect of venipuncture stress on plasma prolactin levels. Int J Gynaecol Obstet. 1985;23:459-462.
Google Scholar | Crossref | Medline12. Muneyyirci-Delale, O, Goldstein, D, Reyes, FI. Diagnosis of stress-related hyperprolactinemia. Evaluation of the hyperprolactinemia rest test. N Y State J Med. 1989;89:205-208.
Google Scholar | Medline13. Ishay, A, Luboshitzky, R. Diagnosis of Hyperprolactinemia: determination of Prolactin Level at Rest. Harefuah. 1998;135:348-407.
Google Scholar | Medline14. Briet, C, Saraval, M, Loric, S, Topolinski-Duyme, H, Fendri, S, Desailloud, R. The use of intravenous catheterisation with a rest period is useful for determination of plasma cortisol levels but not plasma prolactin levels. Ann Endocrinol. 2007;68:34-38.
Google Scholar | Crossref | Medline15. Tsur, A, Dreyfuss, E, Ness-Abramof, R, Pollack, R, Cahn, A. Role of cannulated prolactin test in evaluation of hyperprolactinemia – a retrospective study. Endocr Pract. 2020;26:1304-1311.
Google Scholar | Crossref | Medline16. Avari, P, Sharma, S, Hui, E, Qureshi, A. Cannulated prolactin avoids over-diagnosis and unnecessary investigations in normoprolactinaemic patients. Presented at Society for Endocrinology BES 2017, Harrogate, UK. Endocr Abstr. 2017;50:P293.
Google Scholar17. Molitch, ME. Nonfunctioning pituitary tumors and pituitary incidentalomas. Endocrinol Metab Clin North Am. 2008;37:151-171.
Google Scholar | Crossref | Medline18. Pereira-Lima, JF, Leães, CG, Freitas Neto, FM, Barbosa, MV, da Silva, ALM, Oliveira, MDC. Hyperprolactinemia and body weight: prevalence of obesity and overweight in patients with hyperprolactinemia. Res J Endocrinol Metab. 2013;1:2.
Google Scholar | Crossref